Hyperprolactinaemia with amisulpride

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Psychopharmacological agents are integral to managing psychiatric conditions.
• Drug selection is guided by patient psychopathology and diagnostic classifications.
• The pharmaceutical industry continuously introduces new medications for clinical use.

Observation:

• Antipsychotic medications primarily treat psychotic disorders.
• Newer antipsychotics, like amisulpride, are sometimes used for affective disorders due to receptor profiles.
• A patient with recurrent hospitalizations experienced escalating amisulpride doses.

Findings:

• High-dose amisulpride did not yield therapeutic benefits for the patient.
• The patient experienced significant adverse effects from the increased amisulpride dosage.
• Treatment challenges included frequent hospitalizations and changes in care providers.

Implications:

• This case highlights potential risks of escalating antipsychotic doses without clear therapeutic gain.
• Careful patient monitoring is crucial when using atypical antipsychotics off-label.
• Further research is needed on optimal dosing and side effect management of amisulpride in non-psychotic conditions.